What providers should know about treating constipation in the PACE population.

A Review of Treatment Guidelines for Constipation in the PACE Population

Constipation is a common complaint in the PACE population, and understandably so. The incidence of constipation is higher in older populations when compared to younger populations. And it’s even more common in older women.While constipation is not considered a natural consequence of aging, the PACE population is affected by age-related Read more…

What providers, including LTC pharmacy, should know about GERD.

LTC Pharmacy Notes: A Look at GERD Treatment Recommendations

Gastroesophageal reflux disease (GERD), which develops when stomach acid frequently flows back into the esophagus, is common in long-term care residents. Similar to other conditions, older adults are at a higher risk of complications from chronic GERD, making it important for long-term care providers—including LTC pharmacy services—to stay up to Read more…

What providers, including post-acute care pharmacy, should know about antibiotics.

Being Selective: Why Antibiotic Selection Criteria Is Important to Post-acute Care Pharmacy

Antibiotics are one of the most widely prescribed classes of medications in the United States. They’re also one of the most overly and inappropriately prescribed medications, particularly among the senior population. Constant or inappropriate use of antibiotics can worsen a resident’s health, potentially affecting his or her gastrointestinal, renal, and/or Read more…

The high-dose flu vaccine has been proven effective in seniors, including the PACE population.

Is the High-dose Flu Vaccine More Effective for Seniors, Including the PACE Population?

Adults age 65 and older, including those in the PACE population, are susceptible to serious complications from the influenza, or flu, virus. In the United States, flu complications among seniors cost a staggering $56 billion annually, mainly driven by costs related to hospital admissions and death. This large clinical and Read more…

What phase 2 of the Final Rule will bring for post-acute care pharmacy.

Post-Acute Care Pharmacy Changes Are Coming: The Implications of CMS Final Rule Phase 2

Last year, the Centers for Medicare & Medicaid Services introduced multiple new regulations that affect long-term care pharmacy. The Final Rule for long-term care facilities participating in Medicare and Medicaid programs was published by CMS on Oct. 4, 2016.   The three phases of these regulations have implementation dates of Read more…

Long-term care pharmacy update about the link between diabetes and heart disease.

Staying Ahead in Long-term Care Pharmacy—The Link Between Heart Disease and Diabetes

post-acute care pharmacy providers. In fact, the American Diabetes Association reports that 11.2 million Americans age 65 and older—or approximately 26 percent of that population—have been diagnosed with diabetes. Many more have prediabetes, meaning they’re at risk of developing Type 2 diabetes. These numbers are important because those with diabetes Read more…

Important tips for inhaler use in the PACE population.

Inhale, Exhale: Best Practices Related to Inhaler Use in the PACE Population

Inhalers are used frequently in the elderly population, including PACE participants, to treat chronic obstructive pulmonary disease or asthma. Each inhaler works a little differently, and proper administration technique is important to ensure participants receive the appropriate amount of medication to make a difference in their disease state and improve Read more…